Literature DB >> 12734262

Detection of fluconazole-resistant isolates of Candida glabrata by using an agar screen assay.

Susan M Nelson1, Charles P Cartwright.   

Abstract

The ability of a fluconazole-containing agar screen assay to accurately detect isolates of Candida glabrata resistant to the azole antifungal agent fluconazole was evaluated on a collection of 100 clinical isolates of this organism. Results were correlated with the MIC of fluconazole for these isolates and compared with the results of a previously published disk diffusion-based fluconazole resistance screening test. Agar screen assay results were in categorical agreement with MIC-based determinations for 97% (97/100) of the isolates tested. This correlation was higher than that obtained with the disk diffusion technique, which categorized only 87% (87/100) of isolates correctly, and suggests that the agar screening approach can effectively expedite fluconazole susceptibility testing of C. glabrata isolates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734262      PMCID: PMC154706          DOI: 10.1128/JCM.41.5.2141-2143.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients.

Authors:  Susan Hadley; José A Martinez; Laura McDermott; Barbara Rapino; David R Snydman
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

Review 2.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

3.  Initial use of a broth microdilution method suitable for in vitro testing of fungal isolates in a clinical microbiology laboratory.

Authors:  D M Hacek; G A Noskin; K Trakas; L R Peterson
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

4.  Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.

Authors:  T F Patterson; S G Revankar; W R Kirkpatrick; O Dib; A W Fothergill; S W Redding; D A Sutton; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

5.  International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

Authors:  M A Pfaller; D J Diekema; R N Jones; H S Sader; A C Fluit; R J Hollis; S A Messer
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Detection of fluconazole-resistant Candida strains by a disc diffusion screening test.

Authors:  P Sandven
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  Comparison of four methodologies for rapid and cost-effective identification of Candida glabrata.

Authors:  J P Fenn; E Billetdeaux; H Segal; L Skodack-Jones; P E Padilla; M Bale; K Carroll
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Fluconazole disk diffusion test with methylene blue- and glucose-enriched Mueller-Hinton agar for determining susceptibility of Candida species.

Authors:  S C Lee; C P Fung; N Lee; L C See; J S Huang; C J Tsai; K S Chen; W B Shieh
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

9.  Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.

Authors:  G Kronvall; I Karlsson
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

10.  Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period.

Authors:  M F Price; M T LaRocco; L O Gentry
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.